PTCRA: A Potential Drug Target and Biomarker (G171558)

Target Name: PTCRA

NCBI ID: G171558

PTCRA

PTCRA: A Potential Drug Target and Biomarker

Pancreatic cancer is a leading cause of cancer-related deaths worldwide, with a five-year survival rate of only 12%. Despite advances in treatment, the survival rate for pancreatic cancer remains poor, and there is a high demand for new, effective therapies. One potential drug target and biomarker that has gained attention in the field of pancreatic cancer is PTCRA (padding of the tumor relative area).

PTCRA is a protein that is expressed in various tissues, including the pancreas, and has been shown to be involved in cell signaling pathways that promote cancer growth and progression. PTCRA has also been shown to be overexpressed in pancreatic cancer tissues, which may contribute to its role in the development and progression of this disease.

One of the key challenges in studying PTCRA as a potential drug target is its complex structure and the difficulty in predicting its function. However, recent studies have provided some insights into the potential functions of PTCRA.

One of the main functions of PTCRA is its role in cell signaling pathways. PTCRA has been shown to be involved in the FGF (fibroblast growth factor) signaling pathway, which is a well-established regulator of cell growth and differentiation. FGF signaling is a critical pathway that promotes the development and maintenance of tissues, and it is often disrupted in cancer.

PTCRA has also been shown to be involved in the TGF-β (transforming growth factor-尾) signaling pathway, which is also involved in cell growth and differentiation. TGF-β signaling is a critical pathway that regulates cell proliferation, and it is often disrupted in cancer.

In addition to its role in cell signaling pathways, PTCRA has also been shown to be involved in the regulation of cell adhesion. PTCRA has been shown to be involved in the formation of tight junctions, which are a type of cell adhesion structure that helps to maintain the integrity of tissues.

PTCRA has also been shown to be involved in the regulation of cell migration. PTCRA has been shown to be involved in the migration of cancer cells along the blood-brain barrier, which is a critical barrier that helps to protect the brain from the effects of cancer.

In conclusion, PTCRA is a protein that has been shown to be involved in several key signaling pathways that are involved in cancer growth and progression. While further research is needed to fully understand its functions and potential as a drug target, PTCRA is a promising biomarker and target for future cancer therapies.

Protein Name: Pre T Cell Antigen Receptor Alpha

Functions: The pre-T-cell receptor complex (composed of PTCRA, TCRB and the CD3 complex) regulates early T-cell development

The "PTCRA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTCRA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets